Generate Biomedicines is set to launch its initial public offering on the Nasdaq, aiming to raise $425 million. The company plans to offer its shares at a price range of $15 to $17 each. This move comes as the biotech industry continues to attract investor interest and funding.

Read more at Investing.com: Generate Biomedicines stock seeks $425 million Nasdaq IPO at $15-$17